"CMS Portugal Advises Amethyst Group on First Investment in Portugal with Acquisition of Júlio Teixeira S.A."

"CMS Portugal advised the Amethyst Group on its first investment in Portugal, acquiring Júlio Teixeira S.A., a notable company in nuclear medicine and radiotherapy. The transaction was supported by CMS's Corporate M&A team and financial advice from Banco Finantia. The seller was represented by Morais Leitão and received financial guidance from PwC. Francisco Xavier de Almeida from CMS highlighted the appeal of the Portuguese market for international investors."

**Law Firms Involved in the Transaction:** CMS Portugal advised the Amethyst Group, while Morais Leitão, Galvão Teles, Soares da Silva & Associados represented the seller. **Transaction Overview:** The Amethyst Group, a leading international entity in the healthcare sector, made its first investment in Portugal by acquiring Júlio Teixeira S.A., a notable Portuguese company specializing in nuclear medicine and radiotherapy, recognized for its innovation and clinical excellence. **Legal Teams and Their Roles:** From CMS Portugal, the Corporate M&A team was led by Partner Francisco Xavier de Almeida, with Managing Associate David Apolónia and Associate Francisca Pereira da Cruz participating in the transaction. Morais Leitão, Galvão Teles, Soares da Silva & Associados was represented by partners Jorge Simões Cortez and Constança Carrington, along with Associate Tiago Ribeiro dos Santos.

"CMS Portugal Advises Amethyst Group on First Investment in Portugal with Acquisition of Júlio Teixeira S.A."

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads